|
EspAddText
EspRemoveText
|
Consultation on proposed front-of-package labelling
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Consultation on the renewal of Federal Tobacco Control Strategy
|
Response to consultation
|
2017
|
|
EspAddText
EspRemoveText
|
Federal Monitoring and Reporting Regime for MAID
|
Response to consultation
|
2017
|
|
EspAddText
EspRemoveText
|
Federal monitoring of medical assistance in dying regulations
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Front-of-package labelling consultation
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on potential market for cannabis health products that would not require practitioner oversight
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on proposed vaping products promotion regulations
|
Response to consultation
|
2020
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on the impact of vaping products advertising on youth and non-users of tobacco products
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on tobacco products regulations (plain and standardized appearance)
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada consultation on vaping products labelling and packaging regulations
|
Response to consultation
|
2019
|
|
EspAddText
EspRemoveText
|
Health Canada’s consultation on new health-related labelling for tobacco products
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Health Canada’s Consultation on “Plain and Standardized Packaging”
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Implementation of National Pharmacare
|
Response to consultation
|
2018
|
|
EspAddText
EspRemoveText
|
Regulation of Self-Care Products in Canada
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
|
Response to consultation
|
2016
|
|
EspAddText
EspRemoveText
|
Tamper Resistance under the Controlled Drugs and Substances Act
|
Response to consultation
|
2014
|